Hims & Hers stock (NYSE: HIMS) increased by 16% yesterday following its announcement about expanding into the treatment of menopause and perimenopause—a strategic shift indicating that the company is ...

Hims & Hers Health Inc. HIMS shares are trading lower Tuesday after GoodRx Inc. GDRX announced a collaboration with Novo Nordisk to provide discounted access to two of the most in-demand GLP-1 drugs, ...

CHONGQING, CHINA - MAY 04: In this photo illustration, the logo of Hims & Hers Health, Inc. is displayed on a smartphone screen, with the company's stock market performance and candlestick chart ...

Hims & Hers has experienced a hefty sell-off in recent weeks. This sell-off was mainly caused by short-term turbulence, and I expect the company to resolve these issues in the next quarter. HIMS needs ...

Many investors have fallen in love with Hims & Hers (HIMS) because weight-loss drugs have been a powerful catalyst for this emerging tele-health company’s initial growth. HIMS kept at weight loss ...

Virtual care is steadily expanding as a mainstream healthcare channel, with Hims & Hers Health, Inc. HIMS and Teladoc Health, Inc. TDOC leveraging digital-first models to scale access. HIMS is a ...

Shares of Hims & Hers Health, Inc. (NASDAQ: HIMS) are trending Thursday morning. The San Francisco-based telehealth company announced an international expansion. What To Know: Hims & Hers announced ...

Virtual healthcare platforms are redefining patient access to care, with Hims & Hers Health, Inc. HIMS and LifeMD, Inc. LFMD leading this digital shift. Hims & Hers delivers affordable, ...

Virtual healthcare and physician-focused digital platforms are reshaping U.S. healthcare delivery, with Hims & Hers Health, Inc. HIMS and Doximity, Inc. DOCS at the forefront. Hims & Hers operates a ...